Literature DB >> 12579210

Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast.

Jana Smardová1, Sárka Pavlová, Hana Koukalová.   

Abstract

Tumor suppressor p53 is transcription factor that participates in control of many cellular functions. Somatic mutations of the p53 gene are frequently detected in human cancers. Several methods can be used for identification of p53 mutations, including FASAY - functional analysis of separated alleles in yeast. FASAY distinguishes yeast colonies expressing functional p53 protein from colonies producing a dysfunctional p53 protein simply on the basis of color. The validity of the method depends on a low background level. There are several sources of background as PCR-induced point mutations, low quality of RNA and alternative splicing of intron 9 affecting the p53 carboxy-terminus. In the present work we show that FASAY can be successfully used for analysis of mRNA isolated from blood samples that were collected and stored for 24 hours at 0 degrees C without undesired increase of background. We also measured fidelity of several commonly used DNA polymerases and determined the most suitable kinds of Pfu DNA polymerases for FASAY. Reaction conditions described in this report allow routine analysis of p53 status in leukemic cells using FASAY.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579210     DOI: 10.1007/BF03036739

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

1.  p53 in chronic myeloid leukemia cell lines.

Authors:  S Bi; T Hughes; J Bungey; A Chase; P de Fabritiis; J M Goldman
Journal:  Leukemia       Date:  1992-08       Impact factor: 11.528

2.  Evaluation of methods to detect p53 mutations in ovarian cancer.

Authors:  I Meinhold-Heerlein; E Ninci; H Ikenberg; T Brandstetter; C Ihling; I Schwenk; A Straub; B Schmitt; H Bettendorf; R Iggo; T Bauknecht
Journal:  Oncology       Date:  2001       Impact factor: 2.935

3.  p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry.

Authors:  J Smardová; V Vagunda; E Jandáková; M Vagundová; H Koukalová; J Kovarík; J Zaloudík
Journal:  Neoplasma       Date:  1999       Impact factor: 2.575

4.  A rapid PCR fidelity assay.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; C Ishioka; S H Friend; R Iggo
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

5.  The ADE2 gene from Saccharomyces cerevisiae: sequence and new vectors.

Authors:  A Stotz; P Linder
Journal:  Gene       Date:  1990-10-30       Impact factor: 3.688

6.  High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.

Authors:  H Kashiwazaki; H Tonoki; M Tada; I Chiba; M Shindoh; Y Totsuka; R Iggo; T Moriuchi
Journal:  Oncogene       Date:  1997-11-27       Impact factor: 9.867

7.  Rare somatic p53 mutation identified in breast cancer: a case report.

Authors:  J Smardová; A Nemajerová; M Trbusek; V Vagunda; J Kovarík
Journal:  Tumour Biol       Date:  2001 Mar-Apr

8.  Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.

Authors:  C J Di Como; C Prives
Journal:  Oncogene       Date:  1998-05-14       Impact factor: 9.867

9.  A simple p53 functional assay for screening cell lines, blood, and tumors.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; P Chappuis; A P Sappino; I M Limacher; L Bron; J Benhattar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation.

Authors:  M G Rizzo; A Zepparoni; B Cristofanelli; R Scardigli; M Crescenzi; G Blandino; S Giuliacci; S Ferrari; S Soddu; A Sacchi
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more
  4 in total

1.  TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.

Authors:  Barbara Kantorova; Jitka Malcikova; Jana Smardova; Sarka Pavlova; Martin Trbusek; Nikola Tom; Karla Plevova; Boris Tichy; Sim Truong; Eva Diviskova; Jana Kotaskova; Alexandra Oltova; Nancy Patten; Yvona Brychtova; Michael Doubek; Jiri Mayer; Sarka Pospisilova
Journal:  Tumour Biol       Date:  2014-12-20

2.  p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells.

Authors:  Peixin Dong; Mitsuhiro Tada; Jun-Ichi Hamada; Akihiro Nakamura; Tetsuya Moriuchi; Noriaki Sakuragi
Journal:  Clin Exp Metastasis       Date:  2007-07-18       Impact factor: 5.150

Review 3.  p53, p63 and p73 in the wonderland of S. cerevisiae.

Authors:  Marc Blondel; Cécile Voisset; Olivier Billant
Journal:  Oncotarget       Date:  2017-06-16

4.  Germline mutation in the TP53 gene in uveal melanoma.

Authors:  Nikola Hajkova; Jan Hojny; Kristyna Nemejcova; Pavel Dundr; Jan Ulrych; Katerina Jirsova; Johana Glezgova; Ivana Ticha
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.